agilon health, inc. (NYSE:AGL) Shares Sold by New York State Common Retirement Fund

New York State Common Retirement Fund trimmed its stake in shares of agilon health, inc. (NYSE:AGLFree Report) by 18.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 195,800 shares of the company’s stock after selling 43,142 shares during the quarter. New York State Common Retirement Fund’s holdings in agilon health were worth $2,457,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in the stock. Signaturefd LLC raised its position in shares of agilon health by 73.7% during the 3rd quarter. Signaturefd LLC now owns 1,673 shares of the company’s stock valued at $30,000 after acquiring an additional 710 shares in the last quarter. Van ECK Associates Corp increased its stake in agilon health by 164.7% during the third quarter. Van ECK Associates Corp now owns 4,111 shares of the company’s stock valued at $73,000 after purchasing an additional 2,558 shares during the last quarter. Covestor Ltd lifted its position in shares of agilon health by 1,439.6% in the 3rd quarter. Covestor Ltd now owns 5,912 shares of the company’s stock worth $105,000 after buying an additional 5,528 shares during the last quarter. Nomura Asset Management Co. Ltd. boosted its holdings in shares of agilon health by 128.6% in the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 6,820 shares of the company’s stock valued at $121,000 after buying an additional 3,837 shares during the period. Finally, Handelsinvest Investeringsforvaltning bought a new stake in shares of agilon health during the 4th quarter valued at about $128,000.

agilon health Trading Up 3.1 %

NYSE:AGL opened at $4.98 on Wednesday. The stock has a fifty day simple moving average of $5.38 and a 200 day simple moving average of $8.79. The company has a quick ratio of 1.51, a current ratio of 1.51 and a debt-to-equity ratio of 0.05. The firm has a market capitalization of $2.05 billion, a price-to-earnings ratio of -7.45 and a beta of 0.52. agilon health, inc. has a 1-year low of $4.41 and a 1-year high of $26.75.

agilon health (NYSE:AGLGet Free Report) last released its earnings results on Tuesday, February 27th. The company reported ($0.41) earnings per share for the quarter, missing the consensus estimate of ($0.28) by ($0.13). agilon health had a negative return on equity of 21.74% and a negative net margin of 5.76%. The firm had revenue of $1.06 billion during the quarter, compared to analysts’ expectations of $1.02 billion. During the same period last year, the business earned ($0.14) earnings per share. The business’s revenue was up 71.8% on a year-over-year basis. Sell-side analysts forecast that agilon health, inc. will post -0.33 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts recently weighed in on AGL shares. Benchmark cut their price objective on shares of agilon health from $13.00 to $9.00 and set a “buy” rating on the stock in a research report on Thursday, February 29th. Evercore ISI dropped their price target on shares of agilon health from $7.00 to $6.00 and set an “in-line” rating on the stock in a research report on Wednesday, February 28th. Barclays assumed coverage on shares of agilon health in a research report on Wednesday, March 6th. They set an “underweight” rating and a $5.00 price target on the stock. Royal Bank of Canada dropped their price target on shares of agilon health from $11.00 to $8.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 28th. Finally, Citigroup assumed coverage on shares of agilon health in a research report on Monday, April 22nd. They set a “neutral” rating and a $6.00 price target on the stock. One research analyst has rated the stock with a sell rating, twelve have issued a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $9.32.

Check Out Our Latest Research Report on AGL

agilon health Profile

(Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Further Reading

Want to see what other hedge funds are holding AGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for agilon health, inc. (NYSE:AGLFree Report).

Institutional Ownership by Quarter for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.